Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Psychosis”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)WithdrawnNCT05344365
What this trial is testing

Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Vanda Pharmaceuticals
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Large-scale testing (Phase 3)Study completedNCT01174004
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 199
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Testing effectiveness (Phase 2)Study completedNCT03582137
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Colorado, Denver 74
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Large-scale testing (Phase 3)Looking for participantsNCT06068465
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
Tasly Pharmaceutical Group Co., Ltd 248
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing

The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459
Not applicableApproved For MarketingNCT02762591
What this trial is testing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Post-approval studies (Phase 4)Looking for participantsNCT04373317
What this trial is testing

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Who this might be right for
Parkinson's Disease Psychosis
VA Office of Research and Development 358
Post-approval studies (Phase 4)Study completedNCT04292223
What this trial is testing

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 29
Large-scale testing (Phase 3)Study completedNCT00477672
What this trial is testing

The Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 298
Not applicableUnknownNCT04592965
What this trial is testing

Hallucinations in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 40
Testing effectiveness (Phase 2)Study completedNCT00009048
What this trial is testing

EMD 128130 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Large-scale testing (Phase 3)Study completedNCT00658567
What this trial is testing

Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 123
Not applicableUnknownNCT04579887
What this trial is testing

Presence Hallucination in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 10
Not applicableStudy completedNCT00004826
What this trial is testing

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Memorial Hospital of Rhode Island 60
Load More Results